Literature DB >> 16356162

Bile acid profiles by capillary electrophoresis in intrahepatic cholestasis of pregnancy.

Gustavo Castaño1, Silvia Lucangioli, Silvia Sookoian, Marcelo Mesquida, Abraham Lemberg, Mirta Di Scala, Paula Franchi, Clyde Carducci, Valeria Tripodi.   

Abstract

ICP (intrahepatic cholestasis of pregnancy) is characterized by pruritus and biochemical cholestasis, including raised SBAs (serum bile acids) and, usually, elevated aminotransferases levels. However, AHP (asymptomatic hypercholanaemia of pregnancy) is defined as the presence of total SBA levels above the cut-off value (11 microM) in healthy pregnant women, thus elevation of total SBAs do not necessarily reflect an ICP condition. The aim of the present study was to describe clinical, obstetric, perinatal and biochemical findings, as well as the SBA profile, in pregnant women studied in the third trimester of pregnancy in order to define characteristic patterns of individual bile acids that enable women with ICP to be distinguished from AHP and healthy pregnancies. Free and conjugated ursodeoxycholic (UDCA), cholic (CA), lithocholic (LCA), deoxycholic (DCA) and chenodeoxycholic (CDCA) acids were evaluated by CE (capillary electrophoresis) in 41 patients (15 of them simultaneously by HPLC), in 30 healthy pregnant women and in 10 non-pregnant women. A highly significant correlation between CE and HPLC for total SBAs (r=0.990) and for individual SBAs was found. Normal pregnant women had higher total SBA levels than non-pregnant women (due to an increase in taurine-conjugated dihydroxy SBAs). Women with ICP had higher levels of total SBAs, the free/conjugated ratio, LCA, CA, CDCA and DCA than normal pregnant women. Newborns from women with ICP had lower birth weight and gestational age. Women with AHP had higher levels of conjugated dihydroxy SBAs than normocholanaemic patients, without any evidence of a clinical difference. In conclusion, the present study has shown a clear difference in SBA profiles between ICP and normal pregnancies (including AHP), involving a shift towards a characteristic hydrophobic composition in women with ICP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16356162     DOI: 10.1042/CS20050302

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  24 in total

1.  Inhibition of Na+-taurocholate Co-transporting polypeptide-mediated bile acid transport by cholestatic sulfated progesterone metabolites.

Authors:  Shadi Abu-Hayyeh; Pablo Martinez-Becerra; Siti H Sheikh Abdul Kadir; Clare Selden; Marta R Romero; Myrddin Rees; Hanns-Ulrich Marschall; Jose J G Marin; Catherine Williamson
Journal:  J Biol Chem       Date:  2010-02-20       Impact factor: 5.157

2.  Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3.

Authors:  Chunshan Gui; Yi Miao; Lucas Thompson; Bret Wahlgren; Melissa Mock; Bruno Stieger; Bruno Hagenbuch
Journal:  Eur J Pharmacol       Date:  2008-02-08       Impact factor: 4.432

Review 3.  Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems.

Authors:  Jurate Kondrackiene; Limas Kupcinskas
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

Review 4.  Intrahepatic cholestasis of pregnancy.

Authors:  Victoria Geenes; Catherine Williamson
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

5.  Serum Bile Acids in Intrahepatic Cholestasis of Pregnancy (ICP), Versus Pregnant and Nonpregnant Controls in Asian Indian Women and a Proposed Scoring to Optimize Management in ICP.

Authors:  Nutan Agarwal; Reeta Mahey; Vidushi Kulshrestha; Alka Kriplani; Anoop Saraya; Vikas Sachdev
Journal:  J Obstet Gynaecol India       Date:  2021-06-26

6.  Predictive Value of Serum Cholic Acid and Lithocholic Acid for the Diagnosis in an Intrahepatic Cholestasis of Pregnancy Population with High Levels of Total Bile Acids and the Correlation with Placental Hypoxia-Inducible Factor-1α.

Authors:  Chu-Yun Cheng; Guan-Yin Zeng; Tong Wang; Yan-Hua Su; Feng-Dan Xu; Hong Luo; Hui-Ting Zhong; Xiu-Lan Chen
Journal:  Int J Womens Health       Date:  2022-05-09

7.  Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy.

Authors:  Maria C Estiú; Maria J Monte; Laura Rivas; Maria Moirón; Laura Gomez-Rodriguez; Tomas Rodriguez-Bravo; Jose J G Marin; Rocio I R Macias
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

8.  Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy.

Authors:  Jurate Kondrackiene; Ulrich Beuers; Rimantas Zalinkevicius; Horst-Dietmar Tauschel; Vladas Gintautas; Limas Kupcinskas
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

9.  The normal mechanisms of pregnancy-induced liver growth are not maintained in mice lacking the bile acid sensor Fxr.

Authors:  Alexandra Milona; Bryn M Owen; Saskia van Mil; Dirk Dormann; Chikage Mataki; Mohamed Boudjelal; William Cairns; Kristina Schoonjans; Stuart Milligan; Malcolm Parker; Roger White; Catherine Williamson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-10-08       Impact factor: 4.052

10.  The biochemical diagnosis of intrahepatic cholestasis of pregnancy.

Authors:  Adam Morton; Josephine Laurie
Journal:  Obstet Med       Date:  2018-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.